Your voice for responsible AI governance across health, human services, and life sciences in Massachusetts.
Massachusetts is writing the rules for health AI now.
Massachusetts is setting the rules for health AI on many fronts. Together they will decide what AI companies can deploy here, under what conditions, how they can use data, and where liability falls.
The people who build and understand it should be in the room.
The OpportunityMassachusetts does not need to beat Silicon Valley at building general-purpose AI.
The Commonwealth already possesses the capital, customers, researchers, clinical and social institutions, public infrastructure, and global credibility and can lead the world in applying its AI innovation to its real-world health, human services, and life sciences sectors—together, the largest, fastest-growing, and most consequential areas of AI deployment.
Massachusetts is the U.S. High-Value Reference Market for Health, Human Services, and Life Sciences.
The QuestionWho decides how health data and AI get used, and under what rules?
That question is data sovereignty — for patients and for the Commonwealth. It is being answered right now: in the Attorney General’s office, at the clinical licensure boards, at the Department of Public Health, and in the State Legislature.
MassIntelligence exists so the people who build and deploy these systems are part of answering it.
The SolutionA Massachusetts trade association for the companies that build or deploy AI products and services for health, human services, and life sciences.
The association is organized around data sovereignty, clinical accountability, professional oversight, and the rules governing how AI can be used in these regulated environments.
Rivals in the market, sometimes. Allies on the rules, always.
What we doConvene
We bring the leading AI innovators across three sectors into one working coalition.
Draft
Our sector subcommittees produce the best practices, model regulations, and model statutes that show Massachusetts what responsible deployment looks like.
Clarify
When the rules are unclear, we pursue answers with the relevant agencies and share them across the membership.
Three Sectors
Health
clinical AI, diagnostics, documentation, care delivery
Human Services
elder care, disability services, behavioral health
Life Sciences
research data, clinical trials, discovery
INVITE-ONLY, CAPPED MEMBERSHIPFounding membership is now forming.
An invite-only seat to a capped member-centered association focused on strategic action. Membership is by invitation only and capped by design—a working coalition, not a mailing list.
Executive LeadershipJay A. Youmans, JD – President & CEO
Experienced public policy executive at the intersection of government, healthcare, and emerging technology; served as Senior Advisor to six Massachusetts Public Health Commissioners under governors of both parties; architected rules governing healthcare mergers, expansions, and acquisitions, unlocking $250M annually in social determinants of health investment; designed a statewide COVID-19 mobile testing initiative generating $30M+ in new revenue; helped secure the state’s first $16M investment in AI-powered medication administration for individuals with IDD.
Mahnoosh Mirzaei, MS – Executive Vice President
Biotechnology strategist and operations leader with more than nine years of experience spanning biologics and gene-therapy research, development, and manufacturing; worked across more than ten early-stage and seven clinical-phase programs; conducted research at Harvard Medical School; previously served as a Technical Program Lead at Thermo Fisher Scientific.
Thomas P. Mangan, MPH – Director of Government Affairs
Public health and government-affairs leader with more than a decade of experience in complex state policymaking; previously served as Director of Government Affairs at the Massachusetts Department of Public Health and Senior Pandemic Advisor to the Massachusetts COVID-19 Command Center; helped develop and advance major policies addressing healthcare investment, opioid treatment and prevention, tobacco and vaping regulation, and healthcare-professional education.
Distinguished Academic Advisory Board – In Formation.
To be drawn from leading Massachusetts academic, research, and clinical institutions, bringing independent subject-matter expertise in AI, healthcare, life sciences, and related fields to inform MassIntelligence’s policy and research agenda.